Delving into the Latest Updates on Acharya Nagarjuna University with Synapse

The healthcare sector is facing unprecedented challenges, including rising costs, growing demand, and the need for improved patient outcomes. In response, healthcare organizations are turning to health analytics as a strategic tool to drive sustainability. Health analytics involves the systematic analysis of healthcare data to derive insights and enables making decisions based on the information available. This article explores the impact of health analytics on health sector sustainability, examining its role in enhancing patient care, optimizing resource allocation, reducing costs, and fostering innovation.

2025-05-20·Modern Physics Letters B

HVAC-solar energy performance exploiting Sutterby (AA7075–Ag–Cu/C₆H₉NaO₇) ternary magnetic nanofluid through spinning flow with joule heating

作者: Vardhana, K. Ananda ; Wakif, Abderrahim ; Gangadhar, Kotha

Technologies regarding solar heating, ventilation and air-conditioning (S-HVAC) are aimed at making modern 3D numerical forms that address the Sutterby flow ternary nanofluids circulating onward the convective heating and extendable seats. Heat transport includes joule heating, heat source or sink along with thermal radiation. Using fitting modifications, mathematically conveyed partial differential equations of energy, fixation and strength may decrease into ordinary differential equations (ODEs). They determine ODEs beyond dimension, and for this, the mathematical process is utilized. Copper–silver–aluminum alloys/sodium alginate (Cu–Ag–AA7075/C6H9NaO7) was used to address the behavior of this research work. The natural attributes, for example, heat movement and surface drag coefficients, are numerically prepared and shown in figures and tables when there is an alteration in distant factors. The field of temperature was raised to develop the Biot number. This heat transport rate was hiked to 34.0839% although the shear stress rate was hiked to 32.8043% in the single nanoparticle case compared to the triple nanoparticle case. To validate the analysis, a comparison between the presented and existing is reported under certain assumptions on the flow parameters. It is found that the results are reliable and in line with the existing ones.

2025-04-01·Journal of Molecular Structure

Structural and optoelectronic potential of Ag₂BiO₃-embedded red lead silver-bismuth borate glass-ceramics

作者: Sekhar, A. Venkata ; Bafti, A. ; Veeraiah, N. ; Venkatramaiah, N. ; Brik, Mikhail G. ; Raju, G. Naga ; Pisk, J. ; Bhadrarao, D. ; Kumar, V. Ravi ; Pavic, L.

This study comprehensively examined the structural, optical, and dielec. properties of Pb₃O₄-Bi₂O₃-B₂O₃ glass-ceramics, doped with varying Ag₂O concentrationsXRD and SEM analyses revealed the embedding of non-centrosym. Ag₂BiO₃ ferroelec. crystals (0.6-1.0 μm), whose properties are modeled using GGA and LDA approximations within the Pnn2 space group, aligning with exptl. data.XPS highlights the presence of Ag⁺/Ag⁰ and Bi³⁺/Bi⁵⁺ states, while FTIR spectroscopy indicates increasing structural disorder with up to 0.2 mol% Ag₂O.Optical absorption identifies Ag⁺-Ag⁰ pairs, and dielec. measurements show an increase in permittivity and a.c. conductivity, with impedance decreasing up to 0.2 mol% Ag₂O.Notably, 0.2 mol% Ag₂O optimizes structural reorganization and dielec. performance, enhancing the material′s suitability for spin-orbitronics, optoelectronics, and solid-state batteries.The findings establish these glass-ceramics as next-generation materials for advanced technol. applications.

100 项与 Acharya Nagarjuna University 相关的药物交易

登录后查看更多信息

100 项与 Acharya Nagarjuna University 相关的转化医学

登录后查看更多信息

组织架构

使用我们的机构树数据加速您的研究。

登录

或

查看完整样例数据

管线布局

2025年07月13日管线快照

管线布局中药物为当前组织机构及其子机构作为药物机构进行统计，早期临床1期并入临床1期，临床1/2期并入临床2期，临床2/3期并入临床3期

临床前

27

1

其他

登录后查看更多信息

当前项目

药物(靶点)	适应症	全球最高研发状态

PROTAC AR-V7 Degraders 28(Aurigene Discovery Technologies) ( AR-v7 )	前列腺癌更多	临床前
PROTAC AR-V7 Degraders 14(Aurigene Discovery Technologies) ( AR-v7 )	前列腺癌更多	临床前
PROTAC AR-V7 Degraders 7(Aurigene Discovery Technologies) ( AR-v7 )	前列腺癌更多	临床前
PROTAC AR-V7 Degraders 13(Aurigene Discovery Technologies) ( AR-v7 )	前列腺癌更多	临床前
PROTAC AR-V7 Degraders 17(Aurigene Discovery Technologies) ( AR-v7 )	前列腺癌更多	临床前